Skip Navigation LinksHome > January 2013 - Volume 35 - Issue 1 > Current Practice Managements Regarding Thromboembolic Prophy...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318266bf72
Original Articles

Current Practice Managements Regarding Thromboembolic Prophylaxis Within the Pediatric Sarcoma Patient Population

Crocco, Lauren MD*; Gorlick, Richard MD; Geller, David S. MD*

Collapse Box

Abstract

Objective: Children with cancer are approximately 600 times more likely to develop thromboses than the general pediatric population. Current management strategies for children have been extrapolated from adult studies and prophylaxis guidelines remain controversial. The purpose of this study is to survey the current thromboembolic prophylaxis practice methods of physicians treating pediatric sarcoma patients.

Methods: Physicians involved in the care of sarcoma patients were surveyed using a 5-question survey designed to evaluate current clinical practices.

Results: Of 107 responding physicians, 67 identified themselves as involved in the treatment of pediatric sarcoma patients. The providers most likely to use any form of deep vein thrombosis prophylaxis were orthopedic surgeons (60%), followed by general surgeons (45%), pediatric oncologists (30%), and medical oncologists (25%). Of the providers polled, 48% use mechanical forms, 20% use chemical forms, and 31% use a combination.

Conclusions: Currently, there is a lack of consensus regarding thromboembolic prophylaxis for pediatric sarcoma patients.

© 2013 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.